监管“零容忍”不容“看门人”再装睡

Group 1 - The core viewpoint of the articles emphasizes the regulatory tightening on the responsibilities of sponsors in the capital market, highlighting the introduction of a new classification for sponsors who have been suspended from business due to misconduct [1][2][3] - The update from the China Securities Association has increased the number of suspended sponsors to 15, indicating a zero-tolerance approach towards historical violations and reinforcing the importance of sponsors' diligence and accountability [1][2] - The regulatory framework has been revised to enhance the public disclosure mechanism for negative evaluations of sponsors, which aims to improve the overall quality of practice in the industry and ensure that sponsors fulfill their roles effectively [1][2] Group 2 - Recent enforcement actions by the China Securities Regulatory Commission (CSRC) have intensified scrutiny on intermediary institutions, with 95 cases of negligence reported last year, marking a continuous increase over three years [2][3] - The regulatory approach reflects a commitment to thorough oversight and accountability across the entire issuance and listing process, addressing issues such as fraudulent issuance and inadequate supervision by sponsors [2][3] - The case of Zixin Pharmaceutical illustrates that sponsors can be held accountable for past failures regardless of their current status, emphasizing the need for higher standards in project selection, quality control, and compliance within the investment banking sector [2][3]